Assessing the Economic Value of Anticancer Therapies

1. Front Matter

   Pages I-XI

   PDF

2. Introduction

   • Niels Neymark

   Pages 1-8

3. Epidemiology of Cancer

   • Niels Neymark

   Pages 9-14

4. Cancer and Some Basics of the Main Treatment Modalities

   • Niels Neymark

   Pages 15-27

5. A Brief Introduction to Economic Evaluation

   • Niels Neymark

   Pages 28-41

6. The Economic Burden of Cancer

   • Niels Neymark

   Pages 42-53

7. Breast Cancer

   • Niels Neymark

   Pages 54-78

8. Lung Cancer

   • Niels Neymark

   Pages 79-96

9. Colorectal Cancer

   • Niels Neymark

   Pages 97-113

10. Prostate Cancer

    • Niels Neymark

    Pages 114-132

11. Genitourinary and Gynecological Cancer

    • Niels Neymark

    Pages 133-155

12. Hematological Malignancies

    • Niels Neymark

    Pages 156-182

13. Supportive Care I: Emesis and Infections

    • Niels Neymark

    Pages 183-210

14. Supportive Care II: Hematological Support

    • Niels Neymark

    Pages 211-247

15. Palliative Care

    • Niels Neymark

    Pages 248-262

16. Conclusion

    • Niels Neymark

    Pages 263-275

17. Back Matter

    Pages 277-285

    PDF

With ever increasing demands on the constrained resources available for health care services, no one involved in decision making in health care can continue to ignore the economic costs of the services provided or the relative value for money offered by the available treatments. Economic evaluation has therefore become an important and indispensable tool for medical deci­ sion making, alongside the well-known methods for clinical eval­ uation. This is also true for cancer, despite the aura of sanctity often of surrounding this dreaded disease and the apparent willingness the general population to spend large sums in this area and do "everything possible" for the patients. In recent years, articles dealing with assessing the costs and benefits of various cancer treatments have begun to appear in scientific medical and eco­ nomic journals. This book provides a comprehensive survey and assessment of the current state of the art of economic evaluations and cost ana­ lyses in cancer. It gives an introduction to the methods available for economic evaluations, before surveying and assessing the available publications. Separate chapters are devoted to the most prevalent cancers, and in each chapter the current clinical prac­ tice and research problems are summarized in order to provide a background for the economic analyses. At the end, a summary assessment of the literature is provided along with some sugges­ tions for a future research agenda.

• Krebstherapien
• anti-cancer therapies
• breast cancer
• cancer
• cancer therapy
• colorectal cancer
• cost analyses
• epidemiology
• leukemia
• lung cancer
• lymphoma
• ovarian cancer
• pain
• prostate cancer
• transplantation

• EORTC Health Economics Unit, Brussels, Belgium

  Niels Neymark

Policies and ethics